Inventor · disambiguated record
Jeffrey W. Jacobs
Also filed as: JACOBS JEFFREY · JACOBS JEFFREY W · JACOBS JEFFREY WILLIAM
43 granted patents·19 pending applications·956 citations·filing 1992–2025
98Inventor score
Files withARDELYX INC41VICURON PHARM INC5SUNESIS PHARMACEUTICALS INC3ADELMAN DANIEL C2BRAISTED ANDREW C2
Top patents by PatentIndex Score
62 records- 0196US5919523ADerivatization of solid supports and methods for oligomer synthesisAFFYMETRIX INC·Filed 1997·Granted Jul 6, 1999·533 cites·7 claims
- 0295US5359115AMethods for the synthesis of phosphonate estersAFFYMAX TECH NV·Filed 1992·Granted Oct 25, 1994·172 cites·11 claims
- 0392US7132568B2Aspartyl protease inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2003·Granted Nov 7, 2006·34 cites·48 claims
- 0491US8541448B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersCHARMOT DOMINIQUE·Filed 2011·Granted Sep 24, 2013·6 cites·6 claims
- 0591US8124773B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2007·Granted Feb 28, 2012·10 cites·13 claims
- 0689US9408840B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorderARDELYX INC·Filed 2015·Granted Aug 9, 2016·6 cites·6 claims
- 0788US10543207B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Jan 28, 2020·3 cites·43 claims
- 0887US10376481B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Aug 13, 2019·3 cites·32 claims
- 0987US8969377B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Granted Mar 3, 2015·3 cites·7 claims
- 1087US6797820B2Succinate compounds, compositions and methods of use and preparationVICURON PHARM INC·Filed 2000·Granted Sep 28, 2004·23 cites·48 claims
- 1186US10968246B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2019·Granted Apr 6, 2021·2 cites·27 claims
- 1286US9433640B2Compositions and methods for treating hyperkalemiaARDELYX INC·Filed 2016·Granted Sep 6, 2016·2 cites·29 claims
- 1386US8916569B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Dec 23, 2014·7 cites·44 claims
- 1486US8809339B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 19, 2014·8 cites·36 claims
- 1586US6987104B2Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2002·Granted Jan 17, 2006·12 cites·36 claims
- 1685US10272079B2NHE3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 30, 2019·5 cites·15 claims
- 1785US8815910B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·38 claims
- 1885US8815908B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·32 claims
- 1985US6852752B2Urea compounds, compositions and methods of use and preparationVICURON PHARM INC·Filed 2000·Granted Feb 8, 2005·17 cites·26 claims
- 2084US11318129B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2020·Granted May 3, 2022·1 cites·19 claims
- 2183US10385024B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Granted Aug 20, 2019·3 cites·36 claims
- 2282US2024366589A1Nhe3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2024·Application pending·0 cites
- 2381US12016856B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2022·Granted Jun 25, 2024·0 cites·2 claims
- 2481US9006281B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Granted Apr 14, 2015·1 cites·15 claims
- 2581US6042789ASystem for parallel synthesis of organic compoundsGLAXO GROUP LTD·Filed 1996·Granted Mar 28, 2000·45 cites·12 claims
- 2680US10392413B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2016·Granted Aug 27, 2019·3 cites·39 claims
- 2778US10940146B2NHE3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 2878US7148242B2N-formyl hydroxylamine compounds, compositions and methods of useNOVARTIS AG·Filed 2002·Granted Dec 12, 2006·11 cites·40 claims
- 2976US8765954B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2012·Granted Jul 1, 2014·1 cites·8 claims
- 3070US6117397ASystem and methods for parallel synthesis of organic compoundsGLAXO GROUP LTD·Filed 1997·Granted Sep 12, 2000·26 cites·14 claims
- 3170US2021186953A1Nhe3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2020·Application pending·0 cites
- 3270US2015150858A1Compounds and compositions for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3369US11813304B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2019·Granted Nov 14, 2023·0 cites·14 claims
- 3469US2024366590A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2024·Application pending·0 cites
- 3569US2025388615A9Substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonistsARDELYX INC·Filed 2024·Application pending·0 cites
- 3667US9867848B2Compositions and methods for treating hyperkalemiaARDELYX INC·Filed 2017·Granted Jan 16, 2018·0 cites·26 claims
- 3766US2024325487A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2023·Application pending·0 cites
- 3865US9919006B2Compositions and methods for treating hyperkalemiaARDELYX INC·Filed 2016·Granted Mar 20, 2018·0 cites·28 claims
- 3964US9549947B2Pharmaceutical compositions for treating hyperkalemiaARDELYX INC·Filed 2016·Granted Jan 24, 2017·0 cites·28 claims
- 4064US9545425B2Pharmaceutical compositions for treating hyperkalemiaARDELYX INC·Filed 2016·Granted Jan 17, 2017·0 cites·28 claims
- 4163US2019374533A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Application pending·0 cites
- 4262US9301951B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 5, 2016·0 cites·40 claims
- 4362US2009149509A1Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2008·Application pending·0 cites
- 4461US9676774B2Compounds and compositions for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 13, 2017·0 cites·6 claims
- 4559US7612059B2Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2005·Granted Nov 3, 2009·0 cites·29 claims
- 4659US2010048609A1Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acidJACOBS JEFFREY W·Filed 2007·Application pending·0 cites
- 4758US9289429B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·33 claims
- 4858US9289430B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·35 claims
- 4958US9278102B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 8, 2016·0 cites·29 claims
- 5058US2025367188A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeffrey W. Jacobs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →